Integrin targeting agents and in-vivo and in-vitro imaging methods using the same

Details for Australian Patent Application No. 2009223235 (hide)

Owner Merck & Co., Inc. VisEn Medical, Inc.

Inventors Duong, Le T.; Coleman, Paul J.; Rajopadhye, Milind; Bednar, Bohumil; Ho, Guojie

Agent Davies Collison Cave

Pub. Number AU-A-2009223235

PCT Pub. Number WO2009/114776

Priority 61/036,495 14.03.08 US

Filing date 13 March 2009

Wipo publication date 17 September 2009

International Classifications

A61K 49/00 (2006.01) Preparations for testing

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/10 (2006.01) Preparations for testing

A61K 49/18 (2006.01) Preparations for testing

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

G01N 33/60 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving radioactive labelled substances

Event Publications

4 November 2010 PCT application entered the National Phase

  PCT publication WO2009/114776 Priority application(s): WO2009/114776

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009223238-Hernia stapler with integrated mesh manipulator

2009223234-System and method for reduced pressure charging